Dr. Asadipooya is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2195 Harrodsburg Rd
Ste 125
Lexington, KY 40504Phone+1 646-929-7870
Education & Training
- NYU Grossman School of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2015 - 2017
- Shiraz University of Medical SciencesClass of 1999
Certifications & Licensure
- KY State Medical License 2018 - 2025
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Excellence Award, recognition of research in Endocrinology, Diabetes and Metabolism Endocrinology Diabetes and Metabolism Department, NYU Langone Medical Center, NYU School of Medicine, 2017
- Researcher of the Month Diabetes Research Program, NYU Langone Medical Center, 2017
- Attending Physician Excellence Award, recognition of practice in Medicine Bushehr University of Medical Sciences, 2009
- Join now to see all
Publications & Presentations
PubMed
- 40 citationsSecondary Osteoporosis and Metabolic Bone Diseases.Mahmoud M Sobh, Mohamed Abdalbary, Sherouk Elnagar, Eman Nagy, Nehal Elshabrawy
Journal of Clinical Medicine. 2022-04-24 - 31 citationsCardiovascular Outcomes of Romosozumab and Protective Role of Alendronate.Kamyar Asadipooya, Ada Weinstock
Arteriosclerosis, Thrombosis, and Vascular Biology. 2019-05-23 - 117 citationsAdvanced Glycation End Products (AGEs), Receptor for AGEs, Diabetes, and Bone: Review of the LiteratureKamyar Asadipooya, Edilfavia Mae Uy
Journal of the Endocrine Society. 2019-10-01
Journal Articles
- Letter to the Editor (Advanced Glycation End Products and esRAGE Are Associated with Bone Turnover and Incidence of Hip Fracture in Older Men)Kamyar Asadipooya, MD, The Journal of Clinical Endocrinology and Metabolism
- Letter to the Editor (Advanced glycation end products and esRAGE are associated with bone turnover and incidence of hip fracture in older men)Kamyar Asadipooya, J Clin Endocrinol Metab, 1/22/2018
- Transient osteoporosis of the hip: review of the literatureAsadipooya K, Graves L, Greene LW, Osteoporos Int, 1/1/2017
- Join now to see all
Abstracts/Posters
- Overactivation of Pro-oncogenic Signaling Pathways in Cancer Stem CellsPatrad E, Sanaat Z, Asadipooya K, Kokhaei P, Rezaei Moghadam A, Tafsiri E, Amani M, Mazani M, Ettehad G, Farassati F, International congress of laboratory and clinic, Tehran, Iran, 1/1/2013
- RALA Signaling Pathway as a Target for Anti-Cancer TherapyBeaudoin CA, Terai K, Gadashova A, Sanaat Z, Asadipooya K, Gartrell R, Esfandyari T, Farassati F, University of Missouri-Kansas City, KS, 1/1/2013
- Endocrine Manifestations of Systemic Mastocytosis in BoneAsadipooya K, Greene LW, Corradi PF, American Society of Bone and Mineral Research (ASBMR), Atlanta, Georgia, 1/15/2016
- Join now to see all
Lectures
- Osteoporosis of Systemic Mastocytosis Might Have to be Treated DifferentlyAtlanta, Georgia - 1/18/2016
- Transient osteoporosis of hip associated with alcohol consumption: A case report and review of literatureHouston, TX - 1/14/2014
- Osteocalcin and Diabetes MellitusDepartment of Endocrinology, Metabolism and Genetics, Kansas University Medical Center, Kansas City, - 1/5./2013
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: